Bendamustine Hydrochloride
Overview
Bendamustine Hydrochloride is a bifunctional alkylating agent used for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin's lymphoma (NHL). It interferes with the growth of cancer cells by causing DNA cross-linking, leading to cell death.
API suppliers (8)
Suppliers of Bendamustine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 8 suppliers.
5 of 8 hold a GMP certificate on record in the EU or UK registers
- Intas Pharmaceuticals Ltd.India1 active DMF GMP on record
- FUXIN LONG RUI PHARMACEUTICAL CO LTD1 active DMF
- CHEMPACIFIC CORPUnited States1 active DMF
- Natco PharmaIndia1 active DMF GMP on record
- LABORCHEMIE APOLDA GMBHGermany1 active DMF GMP on record
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
- ITF CHEMICAL LTDABrazil
- FRESENIUS KABI ONCOLOGY LTDIndia GMP on record
Therapeutic areas
Do you supply Bendamustine Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.